U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Information on Cetuximab (marketed as Erbitux)
  1. Drug Safety and Availability

Information on Cetuximab (marketed as Erbitux)

Information on Cetuximab (marketed as Erbitux)

FDA approves Erbitux (cetuximab) to treat patients with advanced colorectal cancer that has spread to other parts of the body. Erbitux is the first monoclonal antibody approved to treat this type of cancer and is indicated as a combination treatment to be given intravenously with irinotecan, another drug approved to fight colorectal cancer, or alone if patients cannot tolerate irinotecan.

Related Information

Labeling and Regulatory History from Drug@FDA